Overview Adherence Assessment With Travalert Dosing Aid Status: Completed Trial end date: 2010-01-01 Target enrollment: Participant gender: Summary The purpose of the study is to compare adherence in patients on a fixed combination of travoprost 0.004%/timolol 0.5% and patients on a concomitant combination of travoprost 0.004% and timolol 0.5% using the Travalert® device. Phase: Phase 4 Details Lead Sponsor: Alcon ResearchTreatments: Ophthalmic SolutionsTetrahydrozolineTimololTravoprost